CCL Products (India) Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹12,445 Cr
- P/E
- 26.97
- ROE
- 18.04%
- PEG
- 2.45
- Price to sales
- 2.65
- Debt to equity
- 0.46
- 52W high / low
- ₹1,230 / ₹855
- Sales growth (5Y)
- 29.11%
- EBITDA margin
- 16.70%
- Net profit margin
- 8.73%
- Promoter holding
- 46.16%
- Sales (last year)
- ₹4,686 Cr
CCL Products (India) is engaged in the production, trading and distribution of Coffee. The Company has business operations mainly in India, Vietnam and Switzerland countries.(Source : 202003 Annual Report Page No:119)
Guidance scorecard · Q2 FY27 call
What CCL Products's management guided
and where it ranks in Agricultural Food & other Products
Agricultural Food & other Products
RevenueQ2 FY27 call
10–20%- The company is targeting a 15% volume growth consistently, as reiterated by management multiple times.
- EBITDA growth is expected to be in line with volume growth, around 15%, with EBITDA per kg remaining stable (INR130-140 per kg).
- Continued focus on gaining market share in domestic and international markets.
- Expansion initiatives into new products (e.g., banana chips) and B2C categories to support medium to long-term growth.
- International branded business (e.g., Percol) is growing and expected to contribute increasingly.
- Capacity expansion plans (especially in Freeze Dried Coffee, FDC) are underway to support volume growth in 1-2 years.
2 more points from CCL Products's call on revenue
Create a free account to keep reading this call
MarginsQ2 FY27 call
FlatSee what CCL Products said on margins — free account, 30 seconds.
CapexQ2 FY27 call
Planned- Company plans capacity expansion for freeze-dried coffee (FDC) as utilization nears full capacity within 1 to 1.5 years.
- Capacity expansion decision expected by Q4 FY26 or Q1 FY27, considering about 9-12 months project lead time.
- Expansion options include own capacity addition, strategic partnerships, contract manufacturing, or joint ventures; all routes are open given strong balance sheet and cash flows.
- Capex cost for FDC expansion estimated around INR 500 crores, with some inflation adjustments compared to last expansion.
- Working capital and capex allocation will be balanced, and sufficient cash flow and cushion exist to support both.
2 more points from CCL Products's call on capex
Create a free account to keep reading this call
FundraisingQ2 FY27 call
PlannedSee what CCL Products said on fundraising — free account, 30 seconds.
Order bookQ2 FY27 call
Rising- The order book for Q3 and Q4 looks robust, with strong orders in place.
- The company expects to end the year meeting its guidance of around 15% volume growth and similar EBITDA growth.
- November-December period is crucial in deciding future coffee price trends and contract inflows.
- Typically, more contracts get added during November-December (pre-crop) and June-July (Brazil crop).
- Customers have shown a wait-and-watch approach due to price fluctuations but are gradually returning to medium and long-term contracts.
2 more points from CCL Products's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Agricultural Food & other Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Agricultural Food & other Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹911 Cr | 14.0 | |
| 2 | 40%+ | Up 0–2% | ₹129 Cr | 7.0 | |
| 3 | 40%+ | Flat | ₹23 Cr | 9.5 | |
| 4 | 20–40% | Up 2%+ | ₹219 Cr | 15.0 | |
| 5 | 20–40% | Up 2%+ | ₹190 Cr | 17.9 | |
| 6 | 20–40% | Up 0–2% | ₹2,595 Cr | 33.0 |
Sign up free to see every company in the sector ranking and track CCL Products.
Pro shows every company guiding 40%+ revenue growth →Full Agricultural Food & other Products rankingFinancials of CCL Products
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of CCL Products
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 520 | 655 | 608 | 664 | 727 | 773 | 738 | 758 | 836 | 1,056 | 1,127 | 1,051 | 1,224 |
| Expenses + | 407 | 549 | 498 | 554 | 609 | 643 | 601 | 634 | 673 | 897 | 930 | 866 | 1,033 |
| Operating Profit | 113 | 106 | 110 | 111 | 118 | 130 | 137 | 124 | 163 | 159 | 197 | 185 | 192 |
| OPM % | 22% | 16% | 18% | 17% | 16% | 17% | 19% | 16% | 20% | 15% | 18% | 18% | 16% |
| Other Income + | 2 | 0 | 1 | 1 | 4 | 1 | 1 | 3 | 4 | 2 | 1 | 3 | 2 |
| Interest | 11 | 15 | 18 | 23 | 21 | 21 | 27 | 31 | 34 | 34 | 33 | 32 | 30 |
| Depreciation | 10 | 22 | 23 | 22 | 31 | 23 | 24 | 25 | 27 | 34 | 39 | 39 | 40 |
| Profit before tax | 95 | 69 | 70 | 67 | 70 | 87 | 87 | 72 | 106 | 94 | 127 | 116 | 123 |
| Tax % | 10% | 13% | 13% | 5% | 7% | 18% | 15% | 12% | 4% | 23% | 21% | 14% | 7% |
| Net Profit + | 85 | 61 | 61 | 63 | 65 | 71 | 74 | 63 | 102 | 72 | 101 | 100 | 115 |
| EPS in Rs | 6.41 | 4.56 | 4.57 | 4.76 | 4.88 | 5.35 | 5.54 | 4.72 | 7.63 | 5.43 | 7.55 | 7.51 | 8.58 |
Financials of CCL Products
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 881 | 932 | 976 | 1,138 | 1,081 | 1,139 | 1,242 | 1,462 | 2,071 | 2,654 | 3,106 | 4,457 |
| Expenses + | 709 | 727 | 744 | 899 | 836 | 853 | 945 | 1,131 | 1,671 | 2,208 | 2,551 | 3,724 |
| Operating Profit | 171 | 205 | 232 | 239 | 245 | 286 | 298 | 331 | 400 | 445 | 555 | 733 |
| OPM % | 19% | 22% | 24% | 21% | 23% | 25% | 24% | 23% | 19% | 17% | 18% | 16% |
| Other Income + | 3 | 1 | 1 | 5 | 3 | 4 | 3 | 4 | 3 | 6 | 8 | 8 |
| Interest | 14 | 11 | 11 | 8 | 8 | 18 | 17 | 16 | 34 | 78 | 113 | 129 |
| Depreciation | 27 | 28 | 33 | 34 | 32 | 47 | 49 | 57 | 64 | 98 | 98 | 152 |
| Profit before tax | 134 | 167 | 189 | 202 | 209 | 225 | 235 | 261 | 305 | 276 | 352 | 461 |
| Tax % | 30% | 27% | 29% | 27% | 26% | 26% | 22% | 22% | 7% | 9% | 12% | 16% |
| Net Profit + | 94 | 122 | 135 | 148 | 155 | 166 | 182 | 204 | 284 | 250 | 310 | 388 |
| EPS in Rs | 7.06 | 9.18 | 10.12 | 11.14 | 11.64 | 12.47 | 13.70 | 15.36 | 21.35 | 18.73 | 23.24 | 29.07 |
| Dividend Payout % | 21% | 27% | 25% | 22% | 30% | 40% | 29% | 33% | 26% | 24% | 22% | 20% |
Financials of CCL Products
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 395 | 483 | 602 | 713 | 812 | 902 | 1,061 | 1,224 | 1,471 | 1,647 | 1,941 | 2,318 |
| Borrowings + | 229 | 210 | 142 | 311 | 416 | 469 | 559 | 655 | 920 | 1,622 | 1,815 | 1,324 |
| Other Liabilities + | 111 | 81 | 78 | 83 | 166 | 112 | 142 | 164 | 180 | 240 | 459 | 657 |
| Total Liabilities | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 | 4,326 |
| Fixed Assets + | 340 | 417 | 393 | 371 | 383 | 724 | 798 | 882 | 1,257 | 1,252 | 1,622 | 2,027 |
| CWIP | 53 | 0 | 0 | 226 | 424 | 100 | 149 | 160 | 54 | 501 | 450 | 3 |
| Investments | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Assets + | 367 | 382 | 453 | 535 | 613 | 684 | 841 | 1,028 | 1,286 | 1,783 | 2,169 | 2,293 |
| Total Assets | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 | 4,326 |
Financials of CCL Products
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 105 | 161 | 102 | 145 | 162 | 91 | 171 | 116 | 173 | 55 | 290 | 858 |
| Cash from Investing Activity + | -19 | -87 | -20 | -247 | -175 | -88 | -153 | -192 | -307 | -527 | -415 | -70 |
| Cash from Financing Activity + | -93 | -82 | -84 | 129 | 42 | -37 | 64 | 9 | 164 | 559 | 53 | -757 |
| Net Cash Flow | -8 | -8 | -2 | 27 | 29 | -35 | 82 | -67 | 30 | 86 | -72 | 32 |
| Free Cash Flow | 84 | 74 | 84 | -78 | -80 | 2 | 16 | -74 | -159 | -458 | -128 | 788 |
| CFO/OP | 86% | 97% | 67% | 84% | 89% | 50% | 66% | 47% | 52% | 19% | 57% | 124% |
Financials of CCL Products
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 50 | 61 | 58 | 79 | 86 | 88 | 80 | 78 | 68 | 81 | 67 |
| Inventory Days | 116 | 99 | 121 | 97 | 123 | 170 | 198 | 262 | 187 | 185 | 208 | 131 |
| Days Payable | 29 | 8 | 8 | 5 | 35 | 16 | 13 | 23 | 24 | 23 | 44 | 32 |
| Cash Conversion Cycle | 134 | 142 | 174 | 150 | 168 | 240 | 272 | 319 | 241 | 230 | 246 | 166 |
| Working Capital Days | 45 | 37 | 81 | 89 | 43 | 103 | 59 | 77 | 58 | 40 | 42 | 41 |
| ROCE % | 23% | 26% | 27% | 23% | 19% | 18% | 17% | 16% | 16% | 12% | 13% | 16% |
Guidance history
How CCL Products's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q2 FY27 call → | 10–20% | Flat | Planned | Planned | Rising |
| Q1 FY27 call → | 10–20% | Flat | Planned | — | — |
| Q4 FY26 call → | 10–20% | Flat | None planned | — | — |
| Q3 FY26 call → | 20–40% | Flat | Planned | None planned | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
21 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +9.0% | 69% |
| Last 6 months | −17.9% | 25% |
| Last 3 months | −19.3% | 23% |
The price is 24.2% below its all-time high of ₹1,229.7 (13 Jul 2026). Stocks more than 20% below their peak have their score halved, so 42 became 21.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For CCL Products: 0.4 × 69 + 0.4 × 25 + 0.2 × 23 = 42, halved to 21 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What CCL Products's management said in earlier quarters
Others in Agricultural Food & other Products this season
- Uttam Sugar Mills Ltd (Q2 FY27)
Q2 FY27 Revenue (Consolidated):** ₹495.59 Cr, down 15.26% from ₹584.82 Cr in Q2 FY26 . Key investor presentation takeaways from Uttam Sugar Mills Ltd's Q2 FY27
- Norben Tea (Q2 FY27)
Revenue from Operations for the quarter ended 30th September 2026 is ₹273.48 lakhs, compared to ₹238.93 lakhs for the quarter ended 30th September 2025…
- Upsurge Seeds (Q2 FY27)
Revenue from operations for the half year ended 30th September 2026 is ₹13,679.33 lakhs. Key results statement takeaways from Upsurge Seeds of Agriculture Ltd's
- Shree Renuka Sugars Ltd (Q2 FY27)
Year-on-year revenue increase: INR 6,130 million (approximately 34.5% increase) . Key results statement takeaways from Shree Renuka Sugars Ltd's Q2 FY27 results
